Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly activ… Read more
Zhejiang Tailin Bioengineering Co Ltd (300813) - Total Liabilities
Latest total liabilities as of September 2025: CN¥143.92 Million CNY
Based on the latest financial reports, Zhejiang Tailin Bioengineering Co Ltd (300813) has total liabilities worth CN¥143.92 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Tailin Bioengineering Co Ltd - Total Liabilities Trend (2013–2024)
This chart illustrates how Zhejiang Tailin Bioengineering Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Tailin Bioengineering Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Tailin Bioengineering Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Norske Skog Asa
OL:NSKOG
|
Norway | Nkr8.89 Billion |
|
Kumho Industrial Co Ltd
KO:002995
|
Korea | ₩1.27 Trillion |
|
ROX Resources Ltd
AU:RXL
|
Australia | AU$12.10 Million |
|
COTGF
OTCQX:COTGF
|
USA | $10.01 Million |
|
Conduent Inc
NASDAQ:CNDT
|
USA | $1.57 Billion |
|
Sports Toto Berhad
KLSE:1562
|
Malaysia | RM2.76 Billion |
Liability Composition Analysis (2013–2024)
This chart breaks down Zhejiang Tailin Bioengineering Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Tailin Bioengineering Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Tailin Bioengineering Co Ltd (2013–2024)
The table below shows the annual total liabilities of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥139.18 Million | -56.95% |
| 2023-12-31 | CN¥323.27 Million | +17.46% |
| 2022-12-31 | CN¥275.21 Million | +73.64% |
| 2021-12-31 | CN¥158.49 Million | +65.53% |
| 2020-12-31 | CN¥95.75 Million | +153.27% |
| 2019-12-31 | CN¥37.81 Million | -37.43% |
| 2018-12-31 | CN¥60.42 Million | +28.27% |
| 2017-12-31 | CN¥47.10 Million | +18.77% |
| 2016-12-31 | CN¥39.66 Million | +17.37% |
| 2015-12-31 | CN¥33.79 Million | +44.71% |
| 2014-12-31 | CN¥23.35 Million | +36.89% |
| 2013-12-31 | CN¥17.06 Million | -- |